Found 5 matching trials
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations PHASE1 BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Show More Status
Active Not Recruiting
Location
University of Alabama
Learn More & Join Trial
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) PHASE2 This prospective, two-part, single-arm, phase II trial is designed to evalu...
Show More Location
Froedtert Hospital & the Medical College of Wisconsin
Learn More & Join Trial
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations. N/A The purpose of this study is to assess percentage reduction in the of urine...
Show More Location
University of Colorado Hospital
Learn More & Join Trial
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy PHASE2 The goal of this clinical trial is to help learn about the safety and feasi...
Show More Location
University of Kentucky
Learn More & Join Trial
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer PHASE3 The primary objective of the study is to assess the efficacy in terms of CN...
Show More Location
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Learn More & Join Trial